EPO Patent Publication: Oligosaccharide Compounds for Neuro-Ischemic Wounds in Diabetics

ChangeBridge: EPO Bulletin - Therapeutics (A61P)

Published March 18th, 2026

Detected March 25th, 2026

Summary

The European Patent Office has published patent application EP4709393A1 concerning the use of oligosaccharide compounds to prevent the recurrence of neuro-ischemic wounds in diabetic patients. The patent application lists URGO RECHERCHE INNOVATION ET DEVELOPPEMENT as the applicant.

View original document View source feed page

What changed

This document is a publication of a European patent application (EP4709393A1) filed by URGO RECHERCHE INNOVATION ET DEVELOPPEMENT. It details the use of specific oligosaccharide compounds for preventing the recurrence of neuro-ischemic wounds in diabetic patients, with a publication date of March 18, 2026.

As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in therapeutic treatments for diabetic patients, which may be of interest to pharmaceutical companies, healthcare providers, and researchers in the field of wound care and diabetes management.

Source document (simplified)

← EPO Patent Bulletin

USE OF OLIGOSACCHARIDE COMPOUNDS FOR PREVENTING THE RECURRENCE OF NEURO-ISCHEMIC WOUNDS IN DIABETIC PATIENTS

Publication EP4709393A1 Kind: A1 Mar 18, 2026

Applicants

URGO RECHERCHE INNOVATION ET DEVELOPPEMENT

Inventors

BOHBOT, Serge, LAZARO MARTINEZ, Jose Luis

IPC Classifications

A61K 31/7016 20060101AFI20241115BHEP A61K 31/702 20060101ALI20241115BHEP A61K 31/7024 20060101ALI20241115BHEP A61P 17/02 20060101ALI20241115BHEP A61L 15/00 20060101ALI20241115BHEP A61K 9/00 20060101ALI20241115BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →